Delivery Order SPE2DB20D3103-SPE2DB25FM4Z6

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,401.44 firm fixed-price delivery order is for the supply of 4,561,180,762 units of Fentanyl 100 mcg/2 mL vials. The contract has an ultimate completion date of June 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,860.23 firm fixed-price delivery order is for the supply of 4,566,553,942 units of 100 mcg/2 ml fentanyl vials. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,367.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA, valued at $999,999,999 and running through November 2026. This IDC enables the government to procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,201.32 firm fixed-price delivery order is for the supply of 4,566,243,239 units of 100 mcg/2 mL fentanyl vials. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 25, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,798.05 Firm Fixed Price Delivery Order, Contract SPE2DX15D6028, is for the delivery of 4566364047 - FENTANYL 100 MCG/2 25S, with a completion date of November 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,673.80 firm fixed-price delivery order is for the supply of 4567197246 - Fentanyl 100 MCG/2 ML Vial 2ML. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,900.86 issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC). The contract covers the supply of 4566259549 - Fentanyl 2,500 MCG/50 ML Vial, 50 ML, with a performance period ending on October 30, 2024. This award is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,182.37 Firm Fixed Price Delivery Order is for the supply of 4564629508 - Fentanyl 100 MCG/2 ML Vial 2ML, with a performance period ending on May 17, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award is for the delivery of Fentanyl 0.05mg/ml, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $1,122.75. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of fentanyl 100 mcg/2 ml vials. The contract, valued at $1,874.70, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM4Z6
    Delivery Order

This federal contract award, number SPE2DB20D3103|SPE2DB25FM4Z6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,114.50, is for the delivery of 4567089486 - FENTANYL 100 MCG/2 ML VIAL 2ML and has a performance period ending on January 30, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/30/25, 10:23 AM